It was interesting to see budgeted figures versus actuals.
Next quarter will be very interesting - to see whether there is a spike on unexpected increases due to a moving window.
Does anyone know how the Japan sales work in terms of seasonal sales versus govt stockpiling and whether/how much of the initial few quarters' sales were for stockpiling or otherwise?
I'd also love to know how much Relenza (if any) was sold to Japan in that quarter. You'd think that Biota would probably get this sort of detail from GSK, however, it would not be deemed newsworthy - as Wayne and Garth said when they met Alice Cooper - "we're not worthy"...
...BTW, getting sidetracked a bit, but Alice Cooper is a fantastic bloke (and a great golfer) - I met and chatted with him a few years ago on Bonnie Doon Golf Course.
BTA Price at posting:
96.5¢ Sentiment: LT Buy Disclosure: Held
